Clinical Trial Update: A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 study assessing the safety and efficacy of topiramate for Bipolar I disorder has completed the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED